Evotec Investor Day Presentation Deck
November 2020, 103 slides
  1. Evotec
  2. Related Decks
  3. Investor Day Presentation Decks
the autobahn to cures poy ade | Evotec
forward looking statement | Evotec
let talk about as | Evotec
| Evotec
agenda | Evotec
precision and efficiency is not just a skill it is an attitude we want to dramatically expand and accelerate access to better drugs | Evotec
agenda | Evotec
it is just the beginning we put drug discovery ideas and leading technologies across all modalities to action we enable and accelerate the development of precision medicines together with our partners | Evotec
industry dynamics suggest need for disruptive approach in | Evotec
our focus more precision higher efficiency higher returns | Evotec
multimodality is reality | Evotec
new technologies more precision higher speed and efficiency | Evotec
combining best of both worlds | Evotec
our strategy delivers significant growth and value potential a | Evotec
agenda | Evotec
power of novelty and precision opens path to ownership | Evotec
owned pipeline has multiple starting points | Evotec
transactions are the beginning for risk free value creation from | Evotec
we long term value generation | Evotec
large portfolio across modalities moving towards market | Evotec
highly attractive owned individual assets | Evotec
follow on discovery projects are progressing rapidly | Evotec
pipeline will strongly gain visibility with no clinical costs for us | Evotec
unparalleled platform delivers big portfolio of opportunities | Evotec
derived therapies have game changing potential patient at the start so why | Evotec
strong portfolio emerging in and metabolic diseases it | Evotec
paradigm shift for cure | Evotec
durable of blood glucose levels i | Evotec
infection with significant public health burden | Evotec
strong data in various in models lead to phase i | Evotec
a novel biologic to cure | Evotec
stimulate pathway and | Evotec
key target in nerve fiber hypersensitization | Evotec
high unmet medical need no effective treatment | Evotec
phase data support best in class potential | Evotec
two more large indications already on their way | Evotec
agenda | Evotec
building a massive owned clinical pipeline | Evotec
building owned product upside with limited financial risk | Evotec
agenda | Evotec
agenda | Evotec
from patient to patient integration of big data into drug discovery is driving precision medicine | Evotec
we are living in a golden age of disruptive technologies applying these to drug discovery is highly exciting and rewarding | Evotec
precision medicine requires a approach | Evotec
the acceleration of data generation a | Evotec
precision medicine is our focus soc | Evotec
agenda | Evotec
accelerate precision medicine unprecedented throughput and depth unprecedented coverage and sensitivity public domain data | Evotec
high throughput is game changing a a bee | Evotec
is scalable to samples | Evotec
platform is industry leading | Evotec
with unprecedented performance first partner | Evotec
platform is industry leading coverage accuracy machine learning a a a a | Evotec
agenda | Evotec
the foundation of precision medicine a and molecular profiles | Evotec
kidney diseases are very diverse and not well defined always clear | Evotec
approach to | Evotec
strategy is delivering on multiple fronts | Evotec
molecular patient translate to high value partnerships | Evotec
agenda | Evotec
reverting molecular disease phenotypes towards healthy state bes | Evotec
unbiased identification of disease relevant drug candidates a | Evotec
of all drugs fail in late stages of clinical development us billion only | Evotec
superior prediction based on | Evotec
molecular disease profiles are driving a paradigm shift | Evotec
looking at the whole picture with unbiased molecular profiles | Evotec
quantum leap in drug discovery development operational excellence from machine learning to the factory of the future in all modalities | Evotec
agenda | Evotec
more efficient and effective drug discovery and development is a global necessity applying machine learning is the natural evolution beyond operational excellence | Evotec
agenda | Evotec
autobahn creates quantum leap for partners and patients an | Evotec
growth driven by modality integration and data surface | Evotec
more efficient to high value value inflection points | Evotec
significantly faster and more efficient on continuum | Evotec
autobahn creates much better exit points for our partners disarm | Evotec
integrating it all for higher productivity | Evotec
agenda | Evotec
my passion is putting our inventions in patients | Evotec
small molecule computational drug discovery development | Evotec
balancing speed cost probability of technical success on | Evotec
features with molecular design | Evotec
improve quality and reduce costs to accelerate to | Evotec
link all discovery and development work to patients | Evotec
training algorithms with high quality well data | Evotec
future state quantum leap in exploitation of knowledge in all domains to invent and produce medicines of the future | Evotec
agenda | Evotec
we using our deep understanding of data science to deliver critical industry solutions and drive global access to important | Evotec
common data platform coupled to powerful data science a | Evotec
data are captured and archived using common data platform tools accelerate learning | Evotec
generative networks to create faces in silico | Evotec
gan technology to create human like antibodies if a | Evotec
billions of human like antibodies created to screen for activity | Evotec
partner or client antibodies from animals or people are improved for manufacturing and formulation i a | Evotec
dramatic improvement in low aggregation achieved through molecular design with abacus if | Evotec
propriety reagents and methods coupled to and can rapidly move client or partner molecules into the clinic i | Evotec
production processes are small and fit into modular clean rooms that can be for flexibility a he | Evotec
pod facilities are ready for precision medicine while delivering capacity for high demand for a variety of partners | Evotec
is creating a modality digital autobahn for delivering critical industry solutions to partners and clients | Evotec
agenda | Evotec
the shared economy in discovery development | Evotec
| Evotec
eer lee or | Evotec
many thanks for your participation poy ade | Evotec
See More
Evotec
Investor Day Presentation Decks
Drug Manufacturers—Specialty & Generic Decks
Healthcare Decks
Explore Topics
Medicine
Oncology
Drug discovery
Precision medicine
Machine learning
Recent decks by Evotec
Investor Presentation
March 2024
Investor Presentation
July 2022
ESG
February 2022
Results
August 2021
See all presentations by Evotec (5 decks)
Related decks
Exscientia
Results
November 2023
Nuvectis Pharma
Investor Presentation
July 2023
Nuvectis Pharma
Investor Presentation
August 2023
Exscientia
Results
August 2023
Nuvectis Pharma
Investor Presentation
December 2023
Exscientia
Results
May 2022
AstraZeneca
Results
February 2022
AstraZeneca
Results
April 2023
Recent decks by Evotec
See all presentations (5 decks)
Investor Presentation
March 2024
Investor Presentation
July 2022
ESG
February 2022
Results
August 2021
Exscientia
Results
November 2023
Nuvectis Pharma
Investor Presentation
July 2023
Nuvectis Pharma
Investor Presentation
August 2023
Exscientia
Results
August 2023
Nuvectis Pharma
Investor Presentation
December 2023
Exscientia
Results
May 2022
AstraZeneca
Results
February 2022
AstraZeneca
Results
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io